Table 1.

Clinical data on the volume of bone-filling material in procedures using Bio-Oss® and Cytrans®

Treatment group	Patient no.	Age	Gender	Deficit condition (FDI)	T2 (ml)	T3 (ml)	Absorbed amount (%)
Bio-Oss® (n = 8)	1	65	F	Edentulous	3.762	2.538	32.50
	2	59	M	23–27	1.583	1.167	26.30
	3	53	M	26, 27	2.271	1.772	22.00
	4	59	F	14–17	4.880	3.836	21.40
	5	21	F	14–16	1.428	0.916	35.90
	6	70	F	26, 27	2.163	1.622	25.00
	7	71	F	Edentulous	2.436	1.973	19.00
	8	71	F	Edentulous	3.198	2.581	19.30
Cytrans® (n = 6)	1	67	F	14–17	2.547	2.371	6.90
	2	41	F	16, 17	2.108	1.791	15.00
	3	59	M	25–27	1.506	1.222	18.90
	4	67	M	Edentulous	3.763	3.375	10.30
	5	67	M	Edentulous	2.392	2.150	10.10
	6	67	F	24–27	2.780	2.386	14.20